title: Atenolol for prevention of rebleeding from esophageal varices in hepatic cirrhosis: results of a controlled, randomized pilot study.
authors.forename: H L
authors.initials: HL
authors.lastname: Bonkovsky
authors.forename: M L
authors.initials: ML
authors.lastname: Bonkovsky
authors.forename: P B
authors.initials: PB
authors.lastname: Anderson
authors.forename: R I
authors.initials: RI
authors.lastname: Rothstein
authors.forename: J F
authors.initials: JF
authors.lastname: Erkkinen
mesh_terms: D001262:Atenolol / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004932:Esophageal and Gastric Varices / Q000150:complications*; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D008103:Liver Cirrhosis / Q000150:complications; D010865:Pilot Projects; D011897:Random Allocation
chemical_list: D001262:Atenolol